W.R. Berkley Corp’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.41M Sell
497,064
-349,759
-41% -$3.79M 0.25% 80
2026
Q1
$9.18M Buy
846,823
+534,533
+171% +$5.75M 0.49% 40
2025
Q4
$3.34M Buy
312,290
+14,298
+5% +$152K 0.16% 105
2025
Q3
$3.16M Hold
297,992
– – 0.18% 101
2025
Q2
$3.14M Hold
297,992
– – 0.16% 113
2025
Q1
$3.07M Hold
297,992
– – 0.18% 85
2024
Q4
$3.02M Hold
297,992
– – 0.12% 73
2024
Q3
$3M Buy
+297,992
New +$2.99M 0.17% 71

Other funds holding GPAT

W.R. Berkley Corp's GPAT Position: Q2 2026 in Review

W.R. Berkley Corp reduced its GP-Act III Acquisition Corp (GPAT) stake by 41% in Q2 2026, selling an estimated $3.79M and leaving 497,064 shares worth $5.41M. The position accounts for 0.25% of the portfolio, ranked #80.

W.R. Berkley Corp first reported a position in GPAT in Q3 2024 and has held it in 8 quarters since. The position peaked at $9.18M in Q1 2026. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

  • W.R. Berkley Corp held 497,064 shares of GP-Act III Acquisition Corp worth $5.41M as of Q2 2026.
  • W.R. Berkley Corp sold 349,759 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $3.79M.
  • GP-Act III Acquisition Corp made up 0.25% of W.R. Berkley Corp's portfolio in Q2 2026, its #80 holding.
  • W.R. Berkley Corp first reported a position in GP-Act III Acquisition Corp in Q3 2024 and has held it in 8 quarters since.
  • W.R. Berkley Corp's GP-Act III Acquisition Corp position peaked at $9.18M in Q1 2026.
  • 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on W.R. Berkley Corp's 13F filing for Q2 2026, filed 14 Aug 2026.